The expected 1 Billion dollar market for CGMS (Continuious Blood Glucose Monitor), will soon have another competitor to compete with MiniMed and DexCom, it’s the Navigator from Abbott Diabetes Care. This was one of the main reasons Abbott bought TherasSense, to gain control of the new sensor technology. It looks …

Breast-feeding your baby can cut your risk of developing type 2 diabetesby15% a year and reduce the risk of breast and ovarian cancer.

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

Having either a large waistline or being overweight raises a person’s risk of developing type 2 diabetes, but the combination of the two is most dangerous, a study shows.

Eating just one salad a day provides even greater health benefits than previously thought.

Only 32% of patients could correctly calculate the amount of carbohydrates consumed in a 20-ounce properly labeled bottle of soda that had 2.5 servings in the bottle.

A series of fairly low-tech innovations radically transformed diabetes care in a busy family medicine program in just over a year’s time, exceeding insurance company pay-for-performance benchmarks.

Many patients stop taking their medicine far sooner than they should, researchers say, and that decision can be deadly when the drugs treat heart disease or diabetes. Two new studies show that nonadherence to medication is common among recent MI patients and in those with diabetes, resulting in higher mortality.

The hope for a cure fails: Two years after receiving transplants of insulin-producing beta islet cells, only five of 36 patients with type 1 diabetes remained free of the need for insulin injections.

Doxazosin appears to work synergistically with acarbose to improve metabolic control in patients with impaired glucose tolerance.